150 related articles for article (PubMed ID: 22752941)
1. Glucose perturbations and cardiovascular risk: challenges and opportunities.
Rydén L; Mellbin L
Diab Vasc Dis Res; 2012 Jul; 9(3):170-6. PubMed ID: 22752941
[TBL] [Abstract][Full Text] [Related]
2. Diabetes, prediabetes and cardiovascular risk.
Mellbin LG; Anselmino M; Rydén L
Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S9-14. PubMed ID: 20489420
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic implications of diabetes in cardiovascular disease.
Cherian B; Meka N; Katragadda S; Arora R
Am J Ther; 2009; 16(6):e51-9. PubMed ID: 19940606
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular manifestations of insulin resistance.
Chahwala V; Arora R
Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
[TBL] [Abstract][Full Text] [Related]
5. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
Karasik A
Ann Med; 2005; 37(4):250-8. PubMed ID: 16019723
[TBL] [Abstract][Full Text] [Related]
6. Implications of abnormal glucose metabolism in patients with coronary artery disease.
Anselmino M; Wallander M; Norhammar A; Mellbin L; Rydén L
Diab Vasc Dis Res; 2008 Nov; 5(4):285-90. PubMed ID: 18958838
[TBL] [Abstract][Full Text] [Related]
7. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.
DeFronzo RA; Abdul-Ghani M
Am J Cardiol; 2011 Aug; 108(3 Suppl):3B-24B. PubMed ID: 21802577
[TBL] [Abstract][Full Text] [Related]
8. Prediabetes: the importance of early identification and intervention.
Hsueh WA; Orloski L; Wyne K
Postgrad Med; 2010 Jul; 122(4):129-43. PubMed ID: 20675976
[TBL] [Abstract][Full Text] [Related]
9. Effects of Nordic walking on cardiovascular risk factors in overweight individuals with type 2 diabetes, impaired or normal glucose tolerance.
Fritz T; Caidahl K; Krook A; Lundström P; Mashili F; Osler M; Szekeres FL; Östenson CG; Wändell P; Zierath JR
Diabetes Metab Res Rev; 2013 Jan; 29(1):25-32. PubMed ID: 22887834
[TBL] [Abstract][Full Text] [Related]
10. Improving the adverse cardiovascular prognosis of type 2 diabetes.
O'Keefe JH; Miles JM; Harris WH; Moe RM; McCallister BD
Mayo Clin Proc; 1999 Feb; 74(2):171-80. PubMed ID: 10069357
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.
Zeymer U
Int J Cardiol; 2006 Feb; 107(1):11-20. PubMed ID: 16337493
[TBL] [Abstract][Full Text] [Related]
12. Patient management strategies in type 2 diabetes: current practices and future considerations.
Blonde L
J Manag Care Pharm; 2005 Aug; 11(6 Suppl B):S12-8. PubMed ID: 23570225
[TBL] [Abstract][Full Text] [Related]
13. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.
Roman G; Hancu N
Horm Metab Res; 2009 Feb; 41(2):116-22. PubMed ID: 19214921
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and the metabolic syndrome--when is it best to intervene to prevent?
Haffner S
Atheroscler Suppl; 2006 Apr; 7(1):3-10. PubMed ID: 16504598
[TBL] [Abstract][Full Text] [Related]
15. [Prediabetes: diagnosis, evaluation of chronic complications, and treatment].
Souza CF; Gross JL; Gerchman F; Leitão CB
Arq Bras Endocrinol Metabol; 2012 Jul; 56(5):275-84. PubMed ID: 22911279
[TBL] [Abstract][Full Text] [Related]
16. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.
Deedwania PC; Fonseca VA
Am J Med; 2005 Sep; 118(9):939-47. PubMed ID: 16164876
[TBL] [Abstract][Full Text] [Related]
17. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
Petersen JL; McGuire DK
Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
[TBL] [Abstract][Full Text] [Related]
18. The early treatment of type 2 diabetes.
Pratley RE
Am J Med; 2013 Sep; 126(9 Suppl 1):S2-9. PubMed ID: 23953075
[TBL] [Abstract][Full Text] [Related]
19. Impaired glucose tolerance and impaired fasting glucose.
Rao SS; Disraeli P; McGregor T
Am Fam Physician; 2004 Apr; 69(8):1961-8. PubMed ID: 15117017
[TBL] [Abstract][Full Text] [Related]
20. Effect of a participant-driven health education programme in primary care for people with hyperglycaemia detected by screening: 3-year results from the Ready to Act randomized controlled trial (nested within the ADDITION-Denmark study).
Maindal HT; Carlsen AH; Lauritzen T; Sandbaek A; Simmons RK
Diabet Med; 2014 Aug; 31(8):976-86. PubMed ID: 24646371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
